Analysts have raised their price target for Zydus Wellness from ₹510.23 to ₹530.91, citing shifts in projected profit margins and future earnings estimates.
What's in the News
- Zydus Wellness Limited will hold a Board Meeting on November 5, 2025, at 11:15 Indian Standard Time.
- The agenda includes consideration and approval of unaudited financial results for the quarter and half year ending September 30, 2025.
- The Board will also review Limited Review Reports from Mukesh M. Shah & Co., Chartered Accountants, and the Statutory Auditors, certifying the limited review of the unaudited financial results for the specified period. (Key Developments)
Valuation Changes
- Consensus Analyst Price Target has risen from ₹510.23 to ₹530.91. This reflects an increase of approximately 4%.
- Discount Rate has increased marginally from 12.73% to 12.76%.
- Revenue Growth projections have fallen notably, decreasing from 33.06% to 27.85%.
- Net Profit Margin is expected to improve slightly, moving up from 9.87% to 10.01%.
- Future P/E ratio has increased from 36.42x to 40.47x. This indicates higher expected valuations relative to earnings.
Have other thoughts on Zydus Wellness?
Create your own narrative on this stock, and estimate its Fair Value using our Valuator tool.
Create NarrativeDisclaimer
AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.